Advertisement

Topics

Allogene nets $301mm through initial public offering

10:30 EDT 12 Oct 2018 | Elsevier Business Intelligence

Immuno-oncology firm Allogene Therapeutics Inc. netted $301mm through its initial public offering of 18mm common shares at $1...

Original Article: Allogene nets $301mm through initial public offering

NEXT ARTICLE

More From BioPortfolio on "Allogene nets $301mm through initial public offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...